Javascript must be enabled to continue!
Potential of emodepside for vector-borne disease control
View through CrossRef
Abstract
Background
Emodepside is an anthelmintic used in veterinary medicine that is currently under investigation in human clinical trials for the treatment of soil-transmitted helminths and possibly Onchocerca volvulus. Emodepside targets the calcium-activated voltage-gated potassium slowpoke 1 (SLO-1) channels of presynaptic nerves of pharynx and body wall muscle cells of nematodes leading to paralysis, reduced locomotion and egg laying, starvation, and death. Emodepside also has activity against Drosophila melanogaster SLO-1 channels. Orthologous SLO-1 genes are present in Anopheles gambiae and Aedes aegypti, suggesting that emodepside may have activity against mosquitoes.
Methods
Both Anopheles dirus and Ae. aegypti were blood-fed emodepside across a range of concentrations (1–10,000 nM) and mosquito survival was monitored for 10 days. Co-feeding experiments were also performed with An. dirus blood fed ivermectin at the concentrations that kills 25% (LC25) and 50% (LC50) of mosquitoes with and without emodepside at clinical peak concentration in humans (Cmax) and five times the Cmax, and mosquito survival was monitored for 10 days.
Results
Emodepside had weak mosquito-lethal effects in An. dirus but none observed in Ae. aegypti at the concentrations evaluated. The An. dirus emodepside LC50 was 4,623 [4,159–5,066] ng/ml which is > 100-fold greater than the peak concentrations seen in human. The ivermectin and emodepside co-feed experiment with An. dirus did not indicate any altered effect of ivermectin on mosquito survival when emodepside co-fed at human Cmax or five times that of the human Cmax.
Conclusions
Emodepside was not lethal to An. dirus at human-relevant concentrations and had no effect on Ae. aegypti survival. Thus, mass distribution of emodepside does not appear to be a potential tool for vector-borne disease control. Emodepside induced mortality in An. dirus does suggest that the SLO-1 channel could be a potential target for novel vector control and may warrant further investigation.
Springer Science and Business Media LLC
Title: Potential of emodepside for vector-borne disease control
Description:
Abstract
Background
Emodepside is an anthelmintic used in veterinary medicine that is currently under investigation in human clinical trials for the treatment of soil-transmitted helminths and possibly Onchocerca volvulus.
Emodepside targets the calcium-activated voltage-gated potassium slowpoke 1 (SLO-1) channels of presynaptic nerves of pharynx and body wall muscle cells of nematodes leading to paralysis, reduced locomotion and egg laying, starvation, and death.
Emodepside also has activity against Drosophila melanogaster SLO-1 channels.
Orthologous SLO-1 genes are present in Anopheles gambiae and Aedes aegypti, suggesting that emodepside may have activity against mosquitoes.
Methods
Both Anopheles dirus and Ae.
aegypti were blood-fed emodepside across a range of concentrations (1–10,000 nM) and mosquito survival was monitored for 10 days.
Co-feeding experiments were also performed with An.
dirus blood fed ivermectin at the concentrations that kills 25% (LC25) and 50% (LC50) of mosquitoes with and without emodepside at clinical peak concentration in humans (Cmax) and five times the Cmax, and mosquito survival was monitored for 10 days.
Results
Emodepside had weak mosquito-lethal effects in An.
dirus but none observed in Ae.
aegypti at the concentrations evaluated.
The An.
dirus emodepside LC50 was 4,623 [4,159–5,066] ng/ml which is > 100-fold greater than the peak concentrations seen in human.
The ivermectin and emodepside co-feed experiment with An.
dirus did not indicate any altered effect of ivermectin on mosquito survival when emodepside co-fed at human Cmax or five times that of the human Cmax.
Conclusions
Emodepside was not lethal to An.
dirus at human-relevant concentrations and had no effect on Ae.
aegypti survival.
Thus, mass distribution of emodepside does not appear to be a potential tool for vector-borne disease control.
Emodepside induced mortality in An.
dirus does suggest that the SLO-1 channel could be a potential target for novel vector control and may warrant further investigation.
Related Results
Nonlinear optimal control for robotic exoskeletons with electropneumatic actuators
Nonlinear optimal control for robotic exoskeletons with electropneumatic actuators
Purpose
To provide high torques needed to move a robot’s links, electric actuators are followed by a transmission system with a high transmission rate. For instance, gear ratios of...
Socio-Demographic and Eco-Epidemiological Parameters of Tick-Borne Infections Morbidity in Baikal Region
Socio-Demographic and Eco-Epidemiological Parameters of Tick-Borne Infections Morbidity in Baikal Region
The aim of the work was to compare the main socio-demographic and eco-epidemiological parameters of tick-borne viral encephalitis, tick-borne borrelioses and tick-borne rickettsios...
Knowledge and Awareness about the Mode of Transmission of Vector Borne Diseases among General Public
Knowledge and Awareness about the Mode of Transmission of Vector Borne Diseases among General Public
Vector borne diseases account for more than 17% of other contagious diseases and can be caused either by parasites, bacteria or viruses. Malaria is a parasitic infection caused by ...
Differential Impacts of Extreme Weather Events on Vector-Borne Disease Transmission Across Urban and Rural Settings: A Scoping Review
Differential Impacts of Extreme Weather Events on Vector-Borne Disease Transmission Across Urban and Rural Settings: A Scoping Review
Background/Objectives: Climate change is intensifying vector-borne disease (VBD) transmission globally, causing over 700,000 annual deaths, yet systematic evidence comparing climat...
5.C. Scientific session: Strengthen resilience against emerging vector-borne diseases through the ECDC Fellowship Programmes
5.C. Scientific session: Strengthen resilience against emerging vector-borne diseases through the ECDC Fellowship Programmes
Abstract
Over the past decade, climate change has impacted the transmission of a wide range of vector-borne diseases (VBDs) in...
AAAS AMA: Hi, we’re Maria Elena Bottazzi, Marcia Castro, Kacey Ernst, and Anthony Wilson and we study vector-borne diseases. Ask us anything!
AAAS AMA: Hi, we’re Maria Elena Bottazzi, Marcia Castro, Kacey Ernst, and Anthony Wilson and we study vector-borne diseases. Ask us anything!
Vector-borne diseases – infectious diseases that are carried between
humans or from animals to humans by organisms such as mosquitoes and
ticks – infect over 1 billion people and c...
The need to implement one health approach in controlling vector-borne diseases in Nigeria
The need to implement one health approach in controlling vector-borne diseases in Nigeria
Introduction. The primary goal of this article is to raise attentiveness about the critical need for vector-borne disease control in Nigeria in relation to One Health, as well as t...
Seasonality and the persistence of vector-borne pathogens
Seasonality and the persistence of vector-borne pathogens
Abstract
Many vector-borne diseases are affected by the seasonality of the environment. Yet, seasonality can act on distinct steps of the life-cycle of the pathogen...

